Trial Profile
A prospective, open-label, 3-period study evaluating pharmacokinetics, safety and tolerability of bazedoxifene in combination with atorvastatin in healthy postmenopausal women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2018
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Bazedoxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 Dec 2018 Results published in the Clinical Pharmacology in Drug Development
- 30 Nov 2018 New trial record